Equities

Shandong Buchang Pharmaceuticals Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
603858:SHH

Shandong Buchang Pharmaceuticals Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)16.88
  • Today's Change0.07 / 0.42%
  • Shares traded4.92m
  • 1 Year change+10.18%
  • Beta0.9965
Data delayed at least 15 minutes, as of Jul 11 2025.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. is a China-based company principally engaged in the research, development, manufacture and distribution of Chinese patent medicines. The Company’s main products are compound traditional Chinese medicines, including cerecarton capsules,wenxin granules, as well as danhong injections, among others. Its products are mainly applied to the fields of cardio-cerebrovascular diseases and gynecological diseases. The Company distributes its products within domestic market and to overseas markets, with North China, East China and Central China as its major markets.

  • Revenue in CNY (TTM)11.15bn
  • Net income in CNY-360.55m
  • Incorporated2001
  • Employees7.69k
  • Location
    Shandong Buchang Pharmaceuticals Co LtdNo. 369Zhonghua West Road, Mudan DistrictHEZE 274000ChinaCHN
  • Phone+86 5 305299167
  • Fax+86 5 305299286
  • Websitehttps://www.buchang.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nanjing King-Frind Bchmcl Phrmctcl C Ltd3.80bn733.67m17.71bn1.36k24.112.69--4.650.45460.45462.354.070.40990.60494.162,797,451.007.908.3810.3512.0341.7844.9519.2819.722.0956.950.185823.22-0.19849.70536.096.4334.44-6.04
Liaoning Cheng Da Co Ltd11.40bn469.03m17.84bn3.32k37.170.6027--1.560.31370.31377.4519.350.23735.006.413,436,062.002.053.152.944.5512.7713.958.649.880.863--0.275916.444.70-8.65-10.09-29.33-9.31-27.52
Shandong Buchang Pharmaceuticals Co Ltd11.15bn-360.55m18.67bn7.69k--1.78--1.67-0.341-0.34110.409.470.5420.972213.831,450,148.00-2.430.8521-3.601.2559.0870.57-4.491.320.51760.25390.284157.32-16.91-5.04-273.62---21.53--
China Resources Dubl-Crne Phrmctl Co Ltd11.45bn1.72bn19.41bn13.41k11.191.78--1.691.671.6711.1310.510.69493.445.39853,948.8010.738.9014.4611.9956.9657.3915.4413.131.63--0.095233.53-0.87113.63-2.199.0621.419.15
Joincare Pharmaceutical Group Ind. Co.15.37bn1.38bn21.37bn14.35k15.901.46--1.390.73460.73468.178.010.42562.355.881,071,007.008.368.6017.2118.6661.0362.4219.6417.662.34--0.218327.59-6.175.45-3.909.176.844.56
Data as of Jul 11 2025. Currency figures normalised to Shandong Buchang Pharmaceuticals Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

2.77%Per cent of shares held by top holders
HolderShares% Held
China Southern Asset Management Co., Ltd.as of 31 Dec 20247.98m0.72%
Yinhua Fund Management Co., Ltd.as of 31 Dec 20246.39m0.58%
GF Fund Management Co., Ltd.as of 31 Dec 20243.66m0.33%
China Universal Asset Management Co., Ltd.as of 31 Dec 20243.21m0.29%
China Asset Management Co., Ltd.as of 31 Dec 20242.99m0.27%
The Vanguard Group, Inc.as of 31 May 20252.62m0.24%
Tian Hong Asset Management Co., Ltd.as of 31 Dec 20241.12m0.10%
Harvest Fund Management Co., Ltd.as of 31 Dec 2024925.86k0.08%
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2024894.40k0.08%
Penghua Fund Management Co., Ltd.as of 31 Dec 2024881.03k0.08%
More ▼
Data from 31 Dec 2024 - 30 Apr 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.